ArticleCancer research communications2026

Clinical Evaluation of Ex Vivo Expanded MUC1-Specific Peripheral Blood T Cells for Adoptive Immunotherapy in Relapsed/Refractory Multiple Myeloma.

Erin W Meermeier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.